<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK390803" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK390803/" /><meta name="ncbi_pagename" content="MBD5 Haploinsufficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>MBD5 Haploinsufficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="MBD5 Haploinsufficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/10/27" /><meta name="citation_author" content="Sureni V Mullegama" /><meta name="citation_author" content="Roberto Mendoza-Londono" /><meta name="citation_author" content="Sarah H Elsea" /><meta name="citation_pmid" content="27786435" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK390803/" /><meta name="citation_keywords" content="2q23.1 Microdeletion Syndrome" /><meta name="citation_keywords" content="MBD5-Associated Neurodevelopmental Disorders (MAND)" /><meta name="citation_keywords" content="Pseudo-Angelman Syndrome" /><meta name="citation_keywords" content="2q23.1 Microdeletion Syndrome" /><meta name="citation_keywords" content="MBD5-Associated Neurodevelopmental Disorders (MAND)" /><meta name="citation_keywords" content="Methyl-CpG-binding domain protein 5" /><meta name="citation_keywords" content="MBD5" /><meta name="citation_keywords" content="MBD5 Haploinsufficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="MBD5 Haploinsufficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Sureni V Mullegama" /><meta name="DC.Contributor" content="Roberto Mendoza-Londono" /><meta name="DC.Contributor" content="Sarah H Elsea" /><meta name="DC.Date" content="2016/10/27" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK390803/" /><meta name="description" content="MBD5 haploinsufficiency is a neurodevelopmental disorder characterized by developmental delay / intellectual disability (DD/ID), severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in about 80%; onset is usually around age two years. Sleep disturbances, present in about 80%, can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (60%)." /><meta name="og:title" content="MBD5 Haploinsufficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="MBD5 haploinsufficiency is a neurodevelopmental disorder characterized by developmental delay / intellectual disability (DD/ID), severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in about 80%; onset is usually around age two years. Sleep disturbances, present in about 80%, can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (60%)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK390803/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mbd5-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK390803/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AFC42E03FC4A10000000007360286.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK390803_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK390803_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ftdp-17/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/thctd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK390803_"><span class="title" itemprop="name"><i>MBD5</i> Haploinsufficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: 2q23.1 Microdeletion Syndrome, <i>MBD5</i>-Associated Neurodevelopmental Disorders (MAND)</div><p class="contrib-group"><span itemprop="author">Sureni V Mullegama</span>, PhD, <span itemprop="author">Roberto Mendoza-Londono</span>, MD, and <span itemprop="author">Sarah H Elsea</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK390803_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK390803_ai__"><div class="contrib half_rhythm"><span itemprop="author">Sureni V Mullegama</span>, PhD<div class="affiliation small">Pathology and Laboratory Medicine<br />University of California at Los Angeles<br />David Geffen School of Medicine<br />Los Angeles, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@amagellumvs" class="oemail">moc.liamg@amagellumvs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Roberto Mendoza-Londono</span>, MD<div class="affiliation small">Associate Professor of P&#x000e6;diatrics and Molecular Genetics, University of Toronto<br />The Hospital for Sick Children<br />Division of Clinical and Metabolic Genetics<br />Toronto, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.sdikkcis@azodnem.otrebor" class="oemail">ac.sdikkcis@azodnem.otrebor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sarah H Elsea</span>, PhD<div class="affiliation small">Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@aesle" class="oemail">ude.mcb@aesle</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 27, 2016</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mbd5-dis.Summary" itemprop="description"><h2 id="_mbd5-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is a neurodevelopmental disorder characterized by developmental delay / intellectual disability (DD/ID), severe speech impairment, seizures, sleep disturbances, and abnormal behaviors. Most children lack speech entirely or have single words, short phrases, or short sentences. Seizures are present in about 80%; onset is usually around age two years. Sleep disturbances, present in about 80%, can result in excessive daytime drowsiness. Abnormal behaviors can include autistic-like behaviors (80%) and self-injury and aggression (60%).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Most commonly the diagnosis of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following alterations on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>:</p><ul><li class="half_rhythm"><div>Deletion of 2q23.1 that encompasses all or part of <i>MBD5</i> (~90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>Intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving one or more exons of <i>MBD5</i> (~5%)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic sequence variant in <i>MBD5</i> (~5%)</div></li></ul><p>Rarely, an apparently balanced complex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement of the 2q23.1 region involving <i>MBD5</i> is causative.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> A multidisciplinary approach that typically includes specialists in clinical genetics, neurology, child development, behavioral therapy, nutrition/feeding, speech and language therapy, and occupational and physical therapy is recommended. Infants benefit from enrollment in an early-intervention program, and school-age children benefit from an individualized educational program. Speech therapy (including nonverbal methods of communication) should be introduced early. Seizures, behavior problems, and sleep disturbances are treated in a routine manner.</p><p><i>Surveillance:</i> Periodic neurodevelopmental and behavioral evaluations to assist in the management of cognitive and behavioral problems.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Typically, <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 2q23.1 is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>; in some instances, an <i>MBD5</i> pathogenic deletion or <i>MBD5</i> sequence variant is inherited from a parent who is mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Rarely, parent-to-child transmission of an unbalanced derivative <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> involving the 2q23.1 region occurs. Once the genetic alteration resulting in <i>MBD5</i> haploinsufficiency has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="mbd5-dis.Diagnosis"><h2 id="_mbd5-dis_Diagnosis_">Diagnosis</h2><div id="mbd5-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>, a neurodevelopmental disorder, <b>should be suspected</b> in individuals with the following findings [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>, <a class="bk_pop" href="#mbd5-dis.REF.mullegama.2016.1376">Mullegama &#x00026; Elsea 2016</a>].</p><p><b>Neurologic</b></p><ul><li class="half_rhythm"><div>Intellectual disability (ID), usually moderate to severe</div></li><li class="half_rhythm"><div>Motor delays</div></li><li class="half_rhythm"><div>Severe speech impairment</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Sleep disturbance</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Feeding difficulties, often related to hypotonia</div></li></ul><p><b>Behavior</b></p><ul><li class="half_rhythm"><div>Short attention span</div></li><li class="half_rhythm"><div>Autistic-like behaviors that include gaze avoidance, inattention, and repetitive behaviors</div></li><li class="half_rhythm"><div>Self-injury and/or aggressive behaviors</div></li></ul></div><div id="mbd5-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with one of the following (see <a class="figpopup" href="/books/NBK390803/table/mbd5-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figmbd5disTmoleculargenetictestinguse" rid-ob="figobmbd5disTmoleculargenetictestinguse">Table 1</a>):</p><ul><li class="half_rhythm"><div>Deletion of 2q23.1 that encompasses all or part of <i>MBD5</i> (~90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>Intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving one or more exons of <i>MBD5</i> (~5%)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic sequence variant in <i>MBD5</i> (~5%)</div></li><li class="half_rhythm"><div>Rarely, an apparently balanced complex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement of the 2q23.1 region involving <i>MBD5</i></div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis [CMA] or more comprehensive genomic testing) and <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted</b>
<b>testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing).</p><p>Gene-targeted testing requires the clinician to hypothesize which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Because many inherited disorders share the phenotypic findings of ID, seizures, and behavior problems, most children with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> are diagnosed by the following recommended testing (CMA and/or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or testing to be considered (comprehensive genomic testing sequencing).</p><div id="mbd5-dis.Recommended_FirstTier_Testing"><h4>Recommended First-Tier Testing</h4><p><b>Chromosomal microarray analysis (CMA</b>) should be the first genetic test as about 90% of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is caused by large, nonrecurrent deletions, which cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>MBD5</i>.</p><p>Note: The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of significantly larger or smaller deletions within this region may be clinically distinct from <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> (see <a href="#mbd5-dis.Genetically_Related_Disorders">Genetically Related Disorders</a>).</p></div><div id="mbd5-dis.Options_for_SecondTier_Testing"><h4>Options for Second-Tier Testing</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>MBD5</i> and other genes of interest (see <a href="#mbd5-dis.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> alone is insufficient to support <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>MBD5</i> followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>* (if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found) may be considered in individuals with features that are highly suggestive of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. However, because many of these features overlap with those of many other genetic disorders with ID, seizures, and behavior issues, a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is typically used in lieu of single-gene testing.</p><p>*Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> should include evaluation of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1, which is noncoding, since deletions that include only exon 1 result in <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</p><div id="mbd5-dis.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>MBD5</i> Haploinsufficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK390803/table/mbd5-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mbd5-dis.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MBD5</i></td><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>3</sup></td><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%</td></tr><tr><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td></tr><tr><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_mbd5-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mbd5-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK390803/#mbd5-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="mbd5-dis.TF.1.2"><p class="no_margin">See <a href="#mbd5-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="mbd5-dis.TF.1.3"><p class="no_margin">CMA identifies <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 2q23.1 (<a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> terminal and interstitial deletions).</p></div></dd><dt>4. </dt><dd><div id="mbd5-dis.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="mbd5-dis.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd></dl></div></div></div></div></div></div><div id="mbd5-dis.Clinical_Characteristics"><h2 id="_mbd5-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mbd5-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is a neurodevelopmental disorder that comprises developmental delay / intellectual disability (ID), severe speech impairment, seizures, sleep disturbances, and behavioral problems with autistic features [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>, <a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</a>].</p><p><b>Developmental delays,</b> evident in all children with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> within the first year of life, include delays in gross motor and fine motor development, receptive and expressive language development, and acquisition of social skills. Children typically acquire new skills, without evidence of psychomotor regression.</p><p>Motor delays with poor coordination and broad-based/ataxic gait are seen in more than 70% of individuals. The average age of walking is two to three years [<a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p>Language development is severely impaired [<a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>]. Most reported children lack speech entirely [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>] or have single words or short (2- to 3-word) phrases [<a class="bk_pop" href="#mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</a>] or (2- to 6-word) sentences [<a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p><b>Seizures</b> occur in more than 80% of children [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p>Onset of seizures is usually around age two years [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>, <a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.williams.2010.436">Williams et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.chung.2011.424">Chung et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</a>, <a class="bk_pop" href="#mbd5-dis.REF.shichiji.2013.850">Shichiji et al 2013</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p>Although seizure types have not been well characterized, typically only one seizure type is observed in an individual. Seizure types have included absence spells and generalized tonic-clonic, atonic, sleep-related, and startle-induced atonic seizures [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>, <a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.williams.2010.436">Williams et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.chung.2011.424">Chung et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p>In the few instances in which EEG studies have been performed, patterns were nonspecific; however, a few individuals were reported to have focal spikes and spike-wave complexes [<a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p><p><b>Sleep disturbances,</b> present in about 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, include frequent nighttime waking, apparent night terrors in the early part of sleep, and waking in the early hours of the morning [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>, <a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.williams.2010.436">Williams et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.chung.2011.424">Chung et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>, <a class="bk_pop" href="#mbd5-dis.REF.mullegama.2014.57">Mullegama et al 2014</a>].</p><p>Many exhibit excessive daytime sleepiness [<a class="bk_pop" href="#mbd5-dis.REF.mullegama.2015b.781">Mullegama et al 2015b</a>].</p><p><b>Behavior problems</b> (observed in <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> and other forms of <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> autism) [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>] include the following:</p><ul><li class="half_rhythm"><div>Short attention span and autistic-like behaviors (gaze avoidance, inattention, and repetitive behaviors) [<a class="bk_pop" href="#mbd5-dis.REF.tan.2014.975">Tan et al 2014</a>] and stereotypic and repetitive behaviors (e.g., teeth grinding, chewing of the hands, and repetitive hand movements) are seen in more than 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Self-injury and aggression are seen in more than 60% of individuals.</div></li><li class="half_rhythm"><div>Other behaviors mentioned in approximately 9% of reported individuals include anxiety, hyperactivity, inappropriate happy demeanor, and social withdrawal.</div></li></ul><p><b>Other findings</b> [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>]</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Feeding difficulties</b> and constipation, likely related to hypotonia, in more than 90% of infants</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features</b> (seen in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) that may include broad forehead, thick / highly arched eyebrows, outer ear abnormalities (e.g., forward-facing large earlobes, protruding ears, cupped ears), short nose, depressed or wide nasal bridge, downturned corners of the mouth, everted vermilion of the lower lip, tented and thin vermilion of the upper lip</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Skeletal abnormalities</b> (observed in 65 individuals with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>) including: small hands and feet (~75%), fifth finger clinodactyly (~70%), generalized brachydactyly (~41%), short fifth digit of the hands and feet (40%), and sandal gap (~33%) [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>]</div><div class="half_rhythm">Other musculoskeletal abnormalities mentioned in at least two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals each are hip dysplasia, joint laxity, and scoliosis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Cardiovascular abnormalities</b> (seen in ~10%) including atrial septal defect, ventricular septal defect, and pulmonary valve stenosis</div></li></ul></div><div id="mbd5-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Current data show that <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is due to decreased <i>MBD5</i> dosage, which can result from large or small deletions involving <i>MBD5</i> or pathogenic sequence variants in <i>MBD5</i>. Although no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> distinguish individuals with pathogenic sequence variants from those with deletions, individuals with larger deletions involving multiple genes may exhibit a more severe phenotype.</p></div><div id="mbd5-dis.Penetrance"><h3>Penetrance</h3><p>Clinical features of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> are apparent in all individuals with <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> inactivation of one <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>; however, both phenotypic heterogeneity and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> are observed.</p><p>In some instances, probands have inherited the variant (small <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant) from a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, suggesting that incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and/or <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> may be associated with this condition [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</p></div><div id="mbd5-dis.Nomenclature"><h3>Nomenclature</h3><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> was first recognized when overlapping deletions of 2q23.1 were identified in individuals with intellectual disability (ID) and "pseudo-Angelman" phenotypes using array <a class="def" href="/books/n/gene/glossary/def-item/comparative-genomic-hybridization/">comparative genomic hybridization</a> (array-CGH) [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>].</p><p>This disorder was initially called 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>; however, delineation of the smallest region of overlap among individuals with a 2q23.1 deletion confirmed that <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>MBD5</i> is responsible for the disorder. In addition, subsequent identification of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic sequence variants in <i>MBD5</i> further supports the use of the term "<i>MBD5</i> haploinsufficiency."</p><p>OMIM uses an outdated term for MBD5 <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>: "mental retardation, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> 1"; MRD1 (OMIM <a href="http://omim.org/entry/156200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">156200</a>).</p></div><div id="mbd5-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is not known. Because many individuals with <i>MBD5</i> haploinsufficiency may go undiagnosed, the prevalence may be greater than observed to date.</p><p>Approximately 1% of 4,808 individuals (from 3 cohorts) ascertained for autism spectrum disorder were found to have <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> when assessed for CNVs involving <i>MBD5</i> and for <i>MBD5</i> sequence variants not present in controls [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>].</p><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> has been identified worldwide and is present in all ethnic groups.</p></div></div><div id="mbd5-dis.Genetically_Related_Disorders"><h2 id="_mbd5-dis_Genetically_Related_Disorders_">Genetically Related Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with either <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the 2q23.1 region involving <i>MBD5</i> or <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>MBD5.</i></p><p>Nonrecurrent duplications involving <i>MBD5</i> have been described in 23 individuals to date [<a class="bk_pop" href="#mbd5-dis.REF.mullegama.2014.57">Mullegama et al 2014</a>]. The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is similar to but perhaps less severe than that of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> and includes mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, ID, developmental delay, motor delay, severe language impairment, infantile hypotonia, sleep disturbances, behavioral problems, and autistic-like features.</p></div><div id="mbd5-dis.Differential_Diagnosis"><h2 id="_mbd5-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is broad due to the variable spectrum and presence of relatively common abnormal phenotypes that occur in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (e.g., developmental delay, learning problems, neuropsychiatric disorders). All manifestations of the <i>MBD5</i> haploinsufficiency can also be seen in individuals with other <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> disorders.</p><p>Significant similarity in phenotypic features is observed between <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> and other neurodevelopmental syndromes. Specific disorders to consider in the differential diagnosis of <i>MBD5</i> haploinsufficiency include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/sms/">Smith-Magenis syndrome</a> (SMS)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/angelman/">Angelman syndrome</a> (AS)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/pitt-hopkins/">Pitt-Hopkins syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/rett/">Rett syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/fragilex/">Fragile X syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/kleefstra/">Kleefstra syndrome</a></div></li><li class="half_rhythm"><div>Koolen-De Vries syndrome link <a href="/books/n/gene/mdel17q21_31/"><i>KANSL1-</i>related intellectual disability syndrome</a></div></li></ul></div><div id="mbd5-dis.Management"><h2 id="_mbd5-dis_Management_">Management</h2><div id="mbd5-dis.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Physical and neurologic examination</div></li><li class="half_rhythm"><div>Developmental assessment including assessment by a physical therapist and/or occupational therapist</div></li><li class="half_rhythm"><div>Speech evaluation including feeding evaluation and nutrition consultation as needed</div></li><li class="half_rhythm"><div>Hearing assessment (as part of the routine evaluation of children with speech delay)</div></li><li class="half_rhythm"><div>EEG if seizures are suspected</div></li><li class="half_rhythm"><div>Cardiac evaluation</div></li><li class="half_rhythm"><div>Sleep history</div></li><li class="half_rhythm"><div>Behavioral assessment</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mbd5-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>A multidisciplinary approach to manage the features and specific issues identified is recommended. Specialists in the following fields are often involved: clinical genetics, neurology, child development, behavioral therapy, nutrition/feeding, speech and language therapy, and occupational and physical therapy.</p><p><b>Neurologic</b></p><ul><li class="half_rhythm"><div>Infants benefit from enrollment in an early-intervention program.</div></li><li class="half_rhythm"><div>School-age children benefit from an individualized educational program.</div></li><li class="half_rhythm"><div>Speech therapy with early introduction of nonverbal methods of communication (e.g., sign language and computer-assisted technologies) is appropriate given the high risk for poor or absent speech.</div></li><li class="half_rhythm"><div>Antiepileptic drugs (AEDs) such as valproate, clonazepam, zonisamide, and clobazam appear to be effective in reducing the incidence of seizures [<a class="bk_pop" href="#mbd5-dis.REF.jaillard.2009.847">Jaillard et al 2009</a>, <a class="bk_pop" href="#mbd5-dis.REF.van_bon.2010.163">van Bon et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.williams.2010.436">Williams et al 2010</a>, <a class="bk_pop" href="#mbd5-dis.REF.chung.2011.424">Chung et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.motobayashi.2012.861">Motobayashi et al 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.noh.2012.59">Noh &#x00026; Graham 2012</a>, <a class="bk_pop" href="#mbd5-dis.REF.bonnet.2013.1457">Bonnet et al 2013</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>]. No information is available on response to specific AEDs.</div></li></ul><p><b>Behavior</b></p><ul><li class="half_rhythm"><div>Routine management of behavioral issues associated with severe intellectual disability and/or autism spectrum disorder is indicated.</div></li><li class="half_rhythm"><div>Management of sleep disturbance through a combined approach of targeted sleep hygiene (to develop firm daily schedules) and use of daily medications such as melatonin, clonidine, and trazodone may be considered [<a class="bk_pop" href="#mbd5-dis.REF.mullegama.2015b.781">Mullegama et al 2015b</a>].</div></li><li class="half_rhythm"><div>Routine management is necessary for constipation (which can affect behavior).</div></li></ul></div><div id="mbd5-dis.Surveillance"><h3>Surveillance</h3><p>Appropriate surveillance includes:</p><ul><li class="half_rhythm"><div>Periodic neurodevelopmental and behavioral evaluations to assist in the management of cognitive and behavioral problems;</div></li><li class="half_rhythm"><div>Periodic reevaluations by a clinical geneticist to provide new recommendations and information regarding <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</div></li></ul></div><div id="mbd5-dis.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#mbd5-dis.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mbd5-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="mbd5-dis.Genetic_Counseling"><h2 id="_mbd5-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mbd5-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Almost all cases reported to date have resulted from one of the following:</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving part or all of <i>MBD5</i> (~90% of probands)</div></li><li class="half_rhythm"><div>An intragenic <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (~5% of probands)</div></li><li class="half_rhythm"><div>An <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (~5% of probands)</div></li><li class="half_rhythm"><div>Rarely, an apparently balanced complex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement of the 2q23.1 region involving <i>MBD5</i></div></li></ul></div><div id="mbd5-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Ninety percent of individuals diagnosed with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</div></li><li class="half_rhythm"><div>Some individuals diagnosed with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> have a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent from whom they have inherited a partial or complete <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>MBD5</i> or an <i>MBD5</i> pathogenic sequence variant [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</div></li><li class="half_rhythm"><div>For the accurate assessment of <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>, evaluation of the parents by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> that will detect the genetic alteration identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or an apparently balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of the 2q23.1 region is recommended.</div></li><li class="half_rhythm"><div>If the genetic alteration found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (a possibility that should be communicated to families).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> may appear to be negative because of failure to recognize the disorder in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members with a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>) or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history must be confirmed with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>Risk to sibs is low, as 90% of individuals diagnosed with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</div></li><li class="half_rhythm"><div>If one of the parents has the 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <i>MBD5</i> deletion, or <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to each sib of inheriting the genetic alteration is 50%. Several multigeneration families with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> have been reported [<a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al 2011</a>, <a class="bk_pop" href="#mbd5-dis.REF.hodge.2014.368">Hodge et al 2014</a>].</div></li><li class="half_rhythm"><div>If the 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <i>MBD5</i> deletion, or <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not identified in one of the parents, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is at a 50% risk of inheriting the genetic alteration.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has a 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, <i>MBD5</i> deletion, or <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="mbd5-dis.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of having a child with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mbd5-dis.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the genetic alteration resulting in <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for <i>MBD5</i> haploinsufficiency and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="mbd5-dis.Resources"><h2 id="_mbd5-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>2q23.1 Microdeletion Syndrome</b></div><div><a href="https://www.rarechromo.org/media/information/Chromosome%20%202/2q23.1%20microdeletion%20syndrome%20FTNW.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Unique 2q23.1 microdeletion brochure</a></div></li><li class="half_rhythm"><div><b>2q23.org</b></div><div><a href="http://2q23.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.2q23.org</a></div></li><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li></ul></div><div id="mbd5-dis.Molecular_Genetics"><h2 id="_mbd5-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mbd5-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>MBD5 Haploinsufficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK390803/table/mbd5-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mbd5-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mbd5-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55777" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MBD5</i></a></td><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55777" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q23<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P267" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methyl-CpG-binding domain protein 5</a></td><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MBD5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MBD5 database</a></td><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MBD5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MBD5</a></td><td headers="hd_b_mbd5-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MBD5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MBD5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mbd5-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mbd5-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for MBD5 Haploinsufficiency (<a href="/omim/156200,611472" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK390803/table/mbd5-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mbd5-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/156200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">156200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611472" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611472</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYL-CpG-BINDING DOMAIN PROTEIN 5; MBD5</td></tr></tbody></table></div></div><p>Prior to the identification of <i>MBD5</i> as the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved in 2q23.1 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>, little was known about <i>MBD5</i>.</p><p><b>Gene structure.</b> The primary <i>MBD5</i> transcript (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018328.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_018328.4</a>) contains 15 exons. Exons 1-5 are the noncoding exons, followed by ten coding exons. The translation start site is located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6. See <a href="/books/NBK390803/#mbd5-dis.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p>A second isoform containing eight exons (4 noncoding followed by 4 coding exons) with the same translational start site as the primary transcript has also been reported [Author, personal observation].</p><p><i>De novo</i> deletions involving the noncoding exons have been reported in several cases.</p><p><b>Pathogenic variants.</b> One <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and five frameshift pathogenic sequence variants have been reported to date, consistent with <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> as a mechanism for <i>MBD5</i> haploinsufficiency. All pathogenic sequence variants occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> (<a class="figpopup" href="/books/NBK390803/table/mbd5-dis.T.selected_mbd5_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figmbd5disTselectedmbd5pathogenicvari" rid-ob="figobmbd5disTselectedmbd5pathogenicvari">Table 2</a>).</p><div id="mbd5-dis.T.selected_mbd5_pathogenic_vari" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>MBD5</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK390803/table/mbd5-dis.T.selected_mbd5_pathogenic_vari/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mbd5-dis.T.selected_mbd5_pathogenic_vari_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.150delT</td><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr52HisfsTer31</td><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018328.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_018328<wbr style="display:inline-block"></wbr>​.4</a></td></tr><tr><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.440C&#x0003e;G</td><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser147Ter</td></tr><tr><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.890_891delTA</td><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile297Thrfs</td></tr><tr><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.340_347delAAAAGCAT</td><td headers="hd_h_mbd5-dis.T.selected_mbd5_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys114GlyfsTer35</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> MBD5 has two known <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, 1 (UniProtKB ID # <b>Q9P267-1)</b> and 2 (UniProtKB ID # <b>Q9P267-2)</b> [<a class="bk_pop" href="#mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</a>].</p><p>Isoform 1, the longer primary isoform, has 1,448 amino acids encoded by exons 6-15 [<a class="bk_pop" href="#mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</a>]. The protein has two conserved domains, a methyl-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (MBD) and a proline-tryptophan-tryptophan-proline (PWWP) domain, both of which may be found in chromatin-associated proteins.</p><p>Isoform 2 is encoded by exons 6-9, with <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 9 being retained, resulting in a protein of 851 amino acids that does not contain the PWWP <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p>Isoforms 1 and 2 have amino acids 1-841 in common. In expression studies <a class="bk_pop" href="#mbd5-dis.REF.laget.2010.e11982">Laget et al [2010]</a> showed that while isoform 1 is expressed in all tissues, it is highly expressed in brain and testis, and while isoform 2 is expressed in all tissues, it is highly expressed in brain and ovaries.</p><p>MBD5 belongs to MBD family of proteins, which includes MBD1-6 and MeCp2 (encoded by <i>MECP2</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved in <a href="/books/n/gene/rett/">Rett syndrome</a>). The MBD proteins play key roles in regulating gene transcription. Most MBD proteins participate in chromatin remodeling and mediate gene silencing through their MBD motifs [<a class="bk_pop" href="#mbd5-dis.REF.tao.2014.279">Tao et al 2014</a>]. MBD5, in contrast to other MBD proteins, has a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of nine amino acids in the first third of the <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and an <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of six amino acids in the last third of the domain [<a class="bk_pop" href="#mbd5-dis.REF.laget.2010.e11982">Laget et al 2010</a>]. Using immunocytochemistry, <a class="bk_pop" href="#mbd5-dis.REF.camarena.2014.1003">Camarena et al [2014]</a> showed that MBD5 localizes to non-heterochromatin regions of the nucleus, suggesting that MBD5 acts as a transcriptional activator.</p><p>In addition to the MBD <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, this protein contains a PWWP domain (Pro-Trp-Trp-Pro motif), which consists of 100-150 amino acids found in numerous proteins involved in cell division, growth, and differentiation.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Haploinsufficiency resulting from <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or disruption of one <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is the cause of <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. In extensive expression studies using lymphoblastoid cell lines from persons with various <i>MBD5</i> deletions, <a class="bk_pop" href="#mbd5-dis.REF.talkowski.2011.551">Talkowski et al [2011]</a> showed that <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> expression levels were significantly reduced compared to levels in normal controls.</p><p>Haploinsufficiency of <i>MBD5</i> results in dysregulation of other autism-associated genes, including <i>UBE3A</i> (<a href="/books/n/gene/angelman/">Angelman syndrome</a>), <i>RAI1</i> (<a href="/books/n/gene/sms/">Smith-Magenis syndrome</a>), <i>TCF4</i> (<a href="/books/n/gene/pitt-hopkins/">Pitt-Hopkins syndrome</a>), <i>MEF2C</i> (5q14.3 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>), and <i>FMR1</i> (<a href="/books/n/gene/fragilex/"><i>FMR1</i>-related disorders</a>) [<a class="bk_pop" href="#mbd5-dis.REF.mullegama.2015a.7627">Mullegama et al 2015a</a>]. Network database analyses utilizing databases such as Gene Mania and SFARI Gene show molecular connections between <i>MBD5</i> and several autism spectrum disorder-associated genes. The dysregulation of any of these genes can affect pathways and thus alter risks for phenotypes affecting sleep, language, and seizures present in persons with <i>MBD5</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. Whether MBD5 directly or indirectly regulates some of these genes remains to be determined.</p></div><div id="mbd5-dis.References"><h2 id="_mbd5-dis_References_">References</h2><div id="mbd5-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.bonnet.2013.1457">Bonnet C, Ali Khan A, Bresso E, Vigouroux C, B&#x000e9;ri M, Lejczak S, Deemer B, Andrieux J, Philippe C, Moncla A, Giurgea I, Devignes MD, Leheup B, Jonveaux P. Extended spectrum of MBD5 mutations in neurodevelopmental disorders. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:1457–61.</span> [<a href="/pmc/articles/PMC3831065/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3831065</span></a>] [<a href="/pubmed/23422940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23422940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.camarena.2014.1003">Camarena V, Cao L, Abad C, Abrams A, Toledo Y, Araki K, Araki M, Walz K, Young JI. Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome. <span><span class="ref-journal">EMBO Mol Med. </span>2014;<span class="ref-vol">6</span>:1003–15.</span> [<a href="/pmc/articles/PMC4154129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4154129</span></a>] [<a href="/pubmed/25001218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25001218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.chung.2011.424">Chung BH, Stavropoulos J, Marshall CR, Weksberg R, Scherer SW, Yoon G. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:424–9.</span> [<a href="/pubmed/21271666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21271666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.hodge.2014.368">Hodge JC, Mitchell E, Pillalamarri V, Toler TL, Bartel F, Kearney HM, Zou YS, Tan WH, Hanscom C, Kirmani S, Hanson RR, Skinner SA, Rogers RC, Everman DB, Boyd E, Tapp C, Mullegama SV, Keelean-Fuller D, Powell CM, Elsea SH, Morton CC, Gusella JF, DuPont B, Chaubey A, Lin AE, Talkowski ME. Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. <span><span class="ref-journal">Mol Psychiatry. </span>2014;<span class="ref-vol">19</span>:368–79.</span> [<a href="/pmc/articles/PMC4756476/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4756476</span></a>] [<a href="/pubmed/23587880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23587880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.jaillard.2009.847">Jaillard S, Dubourg C, G&#x000e9;rard-Blanluet M, Delahaye A, Pasquier L, Dupont C, Henry C, Tabet AC, Lucas J, Aboura A, David V, Benzacken B, Odent S, Pipiras E. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:847–55.</span> [<a href="/pmc/articles/PMC3236717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3236717</span></a>] [<a href="/pubmed/18812405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18812405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.laget.2010.e11982">Laget S, Joulie M, Le Masson F, Sasai N, Christians E, Pradhan S, Roberts RJ, Defossez PA. The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e11982.</span> [<a href="/pmc/articles/PMC2917364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2917364</span></a>] [<a href="/pubmed/20700456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20700456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.motobayashi.2012.861">Motobayashi M, Nishimura-Tadaki A, Inaba Y, Kosho T, Miyatake S, Niimi T, Nishimura T, Wakui K, Fukushima Y, Matsumoto N, Koike K. Neurodevelopmental features in 2q23.1 microdeletion syndrome: report of a new patient with intractable seizures and review of literature. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:861–8.</span> [<a href="/pubmed/22407754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22407754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.mullegama.2015a.7627">Mullegama SV, Alaimo JT, Chen L, Elsea SH. Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder. <span><span class="ref-journal">Int J Mol Sci. </span>2015a;<span class="ref-vol">16</span>:7627–43.</span> [<a href="/pmc/articles/PMC4425039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4425039</span></a>] [<a href="/pubmed/25853262" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25853262</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.mullegama.2016.1376">Mullegama SV, Elsea SH. Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND). <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1376.</span> [<a href="/pmc/articles/PMC4989217/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4989217</span></a>] [<a href="/pubmed/27514998" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27514998</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.mullegama.2014.57">Mullegama SV, Rosenfeld JA, Orellana C, van Bon BW, Halbach S, Repnikova EA, Brick L, Li C, Dupuis L, Rosello M, Aradhya S, Stavropoulos DJ, Manickam K, Mitchell E, Hodge JC, Talkowski ME, Gusella JF, Keller K, Zonana J, Schwartz S, Pyatt RE, Waggoner DJ, Shaffer LG, Lin AE, de Vries BB, Mendoza-Londono R, Elsea SH. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:57–63.</span> [<a href="/pmc/articles/PMC3865402/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3865402</span></a>] [<a href="/pubmed/23632792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23632792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.mullegama.2015b.781">Mullegama SV, Pugliesi L, Burns B, Shah Z, Tahir R, Gu Y, Nelson DL, Elsea SH. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes. <span><span class="ref-journal">Eur J Hum Genet. </span>2015b;<span class="ref-vol">23</span>:781–9.</span> [<a href="/pmc/articles/PMC4795052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4795052</span></a>] [<a href="/pubmed/25271084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25271084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.noh.2012.59">Noh GJ, Graham JM Jr. 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:59–62.</span> [<a href="/pubmed/22085995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22085995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.shichiji.2013.850">Shichiji M, Ito Y, Shimojima K, Nakamu H, Oguni H, Osawa M, Yamamoto T. A cryptic microdeletion including MBD5 occurring within the breakpoint of a reciprocal translocation between chromosomes 2 and 5 in a patient with developmental delay and obesity. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:850–5.</span> [<a href="/pubmed/23494922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23494922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.talkowski.2011.551">Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA, Gastier-Foster J, Thrush DL, Kathiresan S, Ruderfer DM, Chiang C, Hanscom C, Ernst C, Lindgren AM, Morton CC, An Y, Astbury C, Brueton LA, Lichtenbelt KD, Ades LC, Fichera M, Romano C, Innis JW, Williams CA, Bartholomew D, Van Allen MI, Parikh A, Zhang L, Wu BL, Pyatt RE, Schwartz S, Shaffer LG, de Vries BB, Gusella JF, Elsea SH. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:551–63.</span> [<a href="/pmc/articles/PMC3188839/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3188839</span></a>] [<a href="/pubmed/21981781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21981781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.tan.2014.975">Tan WH, Bird LM, Thibert RL, Williams CA. If not Angelman, what is it? A review of Angelman-like syndromes. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:975–92.</span> [<a href="/pubmed/24779060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24779060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.tao.2014.279">Tao Y, Wu Q, Guo X, Zhang Z, Shen Y, Wang F. MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">166</span>:279–91.</span> [<a href="/pubmed/24750026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24750026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.van_bon.2010.163">van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Ad&#x000e8;s LC, Peters G, Gibson K, Moloney S, Novara F, Pramparo T, Dalla Bernardina B, Zoccante L, Balottin U, Piazza F, Pecile V, Gasparini P, Guerci V, Kets M, Pfundt R, de Brouwer AP, Veltman JA, de Leeuw N, Wilson M, Antony J, Reitano S, Luciano D, Fichera M, Romano C, Brunner HG, Zuffardi O, de Vries BB. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:163–70.</span> [<a href="/pmc/articles/PMC2987180/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987180</span></a>] [<a href="/pubmed/19809484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19809484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mbd5-dis.REF.williams.2010.436">Williams SR, Mullegama SV, Rosenfeld JA, Dagli AI, Hatchwell E, Allen WP, Williams CA, Elsea SH. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:436–41.</span> [<a href="/pmc/articles/PMC2987257/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987257</span></a>] [<a href="/pubmed/19904302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19904302</span></a>]</div></li></ul></div></div><div id="mbd5-dis.Chapter_Notes"><h2 id="_mbd5-dis_Chapter_Notes_">Chapter Notes</h2><div id="mbd5-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>27 October 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>12 January 2016 (svm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK390803</span><span class="label">PMID: <a href="/pubmed/27786435" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27786435</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ftdp-17/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/thctd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK390803&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK390803/?report=reader">PubReader</a></li><li><a href="/books/NBK390803/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK390803" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK390803" style="display:none" title="Cite this Page"><div class="bk_tt">Mullegama SV, Mendoza-Londono R, Elsea SH. MBD5 Haploinsufficiency. 2016 Oct 27. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK390803/pdf/Bookshelf_NBK390803.pdf">PDF version of this page</a> (195K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mbd5-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mbd5-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mbd5-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mbd5-dis.Genetically_Related_Disorders" ref="log$=inpage&amp;link_id=inpage">Genetically Related Disorders</a></li><li><a href="#mbd5-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mbd5-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mbd5-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mbd5-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mbd5-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mbd5-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mbd5-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55777[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MBD5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4333868" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4333868" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4333868" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4333868" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301487" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301337" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 2q37 Microdeletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 2q37 Microdeletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Doherty ES, Lacbawan FL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21981781" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.</a><span class="source">[Am J Hum Genet. 2011]</span><div class="brieflinkpop offscreen_noflow">Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA, Gastier-Foster J, Thrush DL, Kathiresan S, Ruderfer DM, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2011 Oct 7; 89(4):551-63. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23632792" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder.</a><span class="source">[Eur J Hum Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mullegama SV, Rosenfeld JA, Orellana C, van Bon BW, Halbach S, Repnikova EA, Brick L, Li C, Dupuis L, Rosello M, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2014 Jan; 22(1):57-63. Epub 2013 May 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26942102" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome.</a><span class="source">[Rare Dis. 2014]</span><div class="brieflinkpop offscreen_noflow">The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Walz K, Young JI. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rare Dis. 2014; 2(1):e967151. Epub 2014 Nov 3.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27786435" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27786435" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ee1dd21425a2572f644">MBD5 Haploinsufficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">MBD5 Haploinsufficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:37:37-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AFC42E03FC4A10000000007360286&amp;ncbi_session=CE8AFC42E040EE11_1846SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK390803%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK390803&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK390803/&amp;ncbi_pagename=MBD5 Haploinsufficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AFC42E040EE11_1846SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>